Biological Effects of Hydrogen Water on Subjects with NAFLD: A Randomized, Placebo-Controlled Trial
Branislav Kura, Mária Szántová, Tyler W. LeBaron, Viliam Mojto, Miroslav Barancik, Barbara Szeiffova Bacova, Barbora Kalocayova, Matus Sykora, Ludmila Okruhlicova, Narcisa Tribulova, Anna Gvozdjakova, Zuzana Sumbalova, Jarmila Kucharská, Xenia Faktorova, Martina Jakabovicova, Zuzana Durkovicová, Jan Macutek, Michaela Koscová, Jan Slezak
Antioxidants · 2022 · 11(10) · 1935
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a liver pathology affecting around 25% of the population worldwide. Excess oxidative stress, inflammation and aberrant cellular signaling can lead to this hepatic dysfunction and eventual carcinoma. Molecular hydrogen has been recognized for its selective antioxidant properties and ability to attenuate inflammation and regulate cellular function. We administered hydrogen-rich water (HRW) to 30 subjects with NAFLD in a randomized, double-blinded, placebo-controlled manner for eight weeks. Phenotypically, we observed beneficial trends (p > 0.05) in decreased weight (≈1 kg) and body mass index in the HRW group. HRW was well-tolerated, with no significant changes in liver enzymes and a trend of improved lipid profile and reduced lactate dehydrogenase levels. HRW tended to non-significantly decrease levels of nuclear factor kappa B, heat shock protein 70 and matrix metalloproteinase-9. Interestingly, there was a mild, albeit non-significant, tendency of increased levels of 8-hydroxy-2’-deoxyguanosine and malondialdehyde in the HRW group. This mild increase may be indicative of the hormetic effects of molecular hydrogen that occurred prior to the significant clinical improvements reported in previous longer-term studies. The favorable trends in this study in conjunction with previous animal and clinical findings suggest that HRW may serve as an important adjuvant therapy for promoting and maintaining optimal health and wellness. Longer term studies focused on prevention, maintenance, or treatment of NAFLD and early stages of NASH are warranted.
Study details
- Article type
- Original Research
- Disease / injury model
- Non-alcoholic fatty liver disease (NAFLD)
- Duration
- 8 weeks
- Outcome
- Positive
- Findings
- Hydrogen-rich water (HRW) was well-tolerated and showed favorable trends in reducing BMI in people with NAFLD subjects, though changes in LDH, cholesterol and liver enzymes were not statistically significant. There was a mild, non-significant increase in oxidative stress markers, possibly indicating a hormetic effect. No adverse events were reported.
Classification
- Research Topics
- Study Type
- Study Design
- Species
- Organs & Tissues
- Physiological Systems
- Biomarkers
- 8-hydroxy-2' -deoxyguanosine (8-OHdG)Alanine aminotransferase (ALT)Albumin (ALB)Alkaline phosphatase (ALP)Aspartate Aminotransferase (AST)Body Mass Index (BMI)C-reactive protein (CRP)Cu/Zn Superoxide Dismutase (SOD1)Diastolic Blood Pressure (DBP)Heat Shock Proteins (HSP60, HSP70, HSPs)High-Density Lipoprotein (HDL)Lactate dehydrogenase (LDH)Low-Density Lipoprotein (LDL)Malondialdehyde (MDA)MatrixMetalloproteinase-2 (MMP-2)MatrixMetalloproteinase-9 (MMP-9)Nuclear Factor Kappa B (NF-κB)Superoxide Dismutase (SOD)Systolic Blood Pressure (SBP)TG/HDL RatioTotal CholestrolTriglycerides (TAG)Tumor Necrosis Factor Alpha (TNF-α)Weight
- Methods of Administration
- Countries
- Also
- Highlighted Articles
